Xcout Intel
NERx Biosciences, Inc. competitors & alternatives
The 12 closest competitors and alternatives to NERx Biosciences, Inc. among biotechnology companies — ranked by similarity to what NERx Biosciences, Inc. actually does, not by market-cap band.
Subscribe to see NERx Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About NERx Biosciences, Inc.
NERx Biosciences, Inc. is a small business enterprise headquartered in Indianapolis, Indiana, dedicated to the discovery and development of targeted therapeutics for cancer.
NERx Biosciences, Inc. at a glance
NERx Biosciences, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $200,000 in October 2021. Xcout tracks 10 named people at NERx Biosciences, Inc., including Katie Pawelczak (COO, Director).
NERx Biosciences, Inc. leadership
- Katie PawelczakCOO, Director
- John TurchiCo-Founder, President and CSO, Director
- Robert FeltgenCo-Founder
- Shadia JalalChair
- Katherine MoynihanDirector
- Trent CarrierDirector
4 more named people on record for NERx Biosciences, Inc., with roles, board committees and tenure — see the full roster →
NERx Biosciences, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $200,000 | — | |
| SEC Form D filing | $850,000 | — | |
| — | $2.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 NERx Biosciences, Inc. competitors
Ranked by semantic similarity — how close each company is to NERx Biosciences, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
IpiNovyx Bio, Inc. is a biopharmaceutical company that discovers and develops targeted proteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Utilizing a proprietary technology platform, the company focuses on advancing selective and reversible immunoproteasome inhibitors to create safer and more effective therapies for patients.
Similar biotechnology company
Bakx Therapeutics, Inc. is a private biotechnology company founded in 2020 and based in New York, United States. The company specializes in pre-clinical oncology drug pipelines and novel therapeutics discovery.
Similar biotechnology company
Halda Therapeutics is a life sciences and drug discovery company based in New Haven, Connecticut, focused on developing targeted therapeutics.
Similar biotechnology company
Adnexus Biotechnologies is a drug discovery and biotechnology company headquartered in Texas that focuses on delivering accessible and affordable therapeutic solutions.
Biotech
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Similar biotechnology company
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Biotech
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Similar biotechnology company
NanoSyrinx Ltd. is a biotechnology company incorporated in England and Wales with headquarters in Warwick, focused on advancing targeted drug delivery platforms.
Similar biotechnology company
RenaissThera is a privately held biotechnology company headquartered in Bengaluru, India, dedicated to developing affordable, AI-powered small-molecule targeted therapies.
Similar biotechnology company
Normunity Holding Company, LLC is a biotechnology company developing novel anti-cancer therapies and biologic medicines, including therapeutic antibodies, bispecific antibodies, and T cell engagers. The company utilizes proprietary discovery platforms originating from a partnership with the Yale School of Medicine to target mechanisms at the interface of tumors and the immune system.
Biotech
Nimbus Therapeutics is a biotechnology company that uses structure-based drug discovery and computational chemistry to develop small-molecule medicines. It focuses on therapeutic areas including oncology, autoimmune disease, and metabolic disorders, serving patients through internally developed programs and pharmaceutical partnerships.
Similar biotechnology company
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of NERx Biosciences, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for NERx Biosciences, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →